Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding. - Wikidata - awgldk - TriplyDB

Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding.

Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding.

http://www.wikidata.org/entity/Q37969893

about

Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding.

http://www.wikidata.org/entity/Q37969893

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding.

@en

Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding.

@nl

type

label

Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding.

@en

Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding.

@nl

prefLabel

Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding.

@en

Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding.

@nl

P1433

Q37969893-31B90ECD-EDB9-44E8-A4DC-79877D5E68DB

P1476

Q37969893-65EEBBF8-9188-48D6-B743-2D56241D8607

P2093

Q37969893-CB1D651F-8E1D-4150-81B0-E3E2183B99F0

Q37969893-FB939526-A686-4DF9-A26E-84EA1A9CEA68

P2860

Q37969893-059BA480-C83C-4612-8EFB-200E11E89F0E

Q37969893-0890BEB0-F6E3-4C6D-9E3A-E87BD2FAA268

Q37969893-2FD1EB02-E85C-4340-BEFA-064891BAA1BC

Q37969893-A00FBDAD-41F3-49E9-AF12-D91BEA20B56C

Q37969893-D2443D7D-FB89-49A6-8730-66AF56F88B0F

P304

Q37969893-9392FBFA-4841-4484-8C5C-B10243F3A646

P31

Q37969893-C607FA9C-CDB2-4898-AC4A-DA7E04C4FF70

P356

Q37969893-99322151-BD32-4473-8C44-257AE06AA5DD

P407

Q37969893-35406D60-2416-4F09-8379-475C14BEA071

P433

Q37969893-96D9BFAA-A078-4F98-9D08-95A8169C3D80

P478

Q37969893-2FF1752F-F7EE-4309-9245-CE6442602790

P577

Q37969893-FABB3615-588F-403C-A72A-6C98FF28C0A4

P698

Q37969893-90953A02-46F8-4BE6-8D5E-2F2BAD2DF118

P356

NRCARDIO.2011.206

P1433

Nature Reviews Cardiology

P1476

Acute coronary syndromes in 2011: Walking the tightrope between efficacy and bleeding.

@en

P2093

Christopher P Cannon

http://www.w3.org/2001/XMLSchema#string

Payal Kohli

http://www.w3.org/2001/XMLSchema#string

P2860

RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome

Apixaban with antiplatelet therapy after acute coronary syndrome.

Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease.

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.

In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry®-GWTG™.

P304

69-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCARDIO.2011.206

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22182956

http://www.w3.org/2001/XMLSchema#string